Literature DB >> 2013328

Novel epoxysuccinyl peptides. Selective inhibitors of cathepsin B, in vitro.

M Murata1, S Miyashita, C Yokoo, M Tamai, K Hanada, K Hatayama, T Towatari, T Nikawa, N Katunuma.   

Abstract

A series of new epoxysuccinyl peptides were designed and synthesized to develop a specific inhibitor of cathepsin B. Of these compounds, N-(L-3-trans-ethoxycarbonyloxirane-2-carbonyl)-L-isoleucyl-L-proli ne (compound CA-030) and N-(L-3-trans-propylcarbamoyloxirane-2-carbonyl)-L-isoleucyl-L-prol ine (compound CA-074) were the most potent and specific inhibitors of cathepsin B in vitro. The carboxyl group of proline and the ethyl ester group or the n-propylamide group in the oxirane ring were necessary, the ethyl ester group or the n-propylamide group being particularly effective for distinguishing cathepsin B from other cysteine proteinases such as cathepsins L and H, and calpains.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2013328     DOI: 10.1016/0014-5793(91)80318-w

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  58 in total

1.  Expression and alteration of the S2 subsite of the Leishmania major cathepsin B-like cysteine protease.

Authors:  V J Chan; P M Selzer; J H McKerrow; J A Sakanari
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

2.  Structural basis for inhibition of cathepsin B drug target from the human blood fluke, Schistosoma mansoni.

Authors:  Adéla Jílková; Pavlína Rezácová; Martin Lepsík; Martin Horn; Jana Váchová; Jindrich Fanfrlík; Jirí Brynda; James H McKerrow; Conor R Caffrey; Michael Mares
Journal:  J Biol Chem       Date:  2011-08-10       Impact factor: 5.157

3.  Targeting Cathepsin B for Cancer Therapies.

Authors:  Hang Ruan; Susan Hao; Peter Young; Hongtao Zhang
Journal:  Horiz Cancer Res       Date:  2015 2nd Quarter

4.  Acid-mediated tumor proteolysis: contribution of cysteine cathepsins.

Authors:  Jennifer M Rothberg; Kate M Bailey; Jonathan W Wojtkowiak; Yael Ben-Nun; Matthew Bogyo; Ekkehard Weber; Kamiar Moin; Galia Blum; Raymond R Mattingly; Robert J Gillies; Bonnie F Sloane
Journal:  Neoplasia       Date:  2013-10       Impact factor: 5.715

5.  Cathepsin D deficiency induces lysosomal storage with ceroid lipofuscin in mouse CNS neurons.

Authors:  M Koike; H Nakanishi; P Saftig; J Ezaki; K Isahara; Y Ohsawa; W Schulz-Schaeffer; T Watanabe; S Waguri; S Kametaka; M Shibata; K Yamamoto; E Kominami; C Peters; K von Figura; Y Uchiyama
Journal:  J Neurosci       Date:  2000-09-15       Impact factor: 6.167

6.  Peptidyl vinyl sulphones: a new class of potent and selective cysteine protease inhibitors: S2P2 specificity of human cathepsin O2 in comparison with cathepsins S and L.

Authors:  D Brömme; J L Klaus; K Okamoto; D Rasnick; J T Palmer
Journal:  Biochem J       Date:  1996-04-01       Impact factor: 3.857

7.  Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity.

Authors:  Kaoru Saegusa; Naozumi Ishimaru; Kumiko Yanagi; Rieko Arakaki; Kouichi Ogawa; Ichiro Saito; Nobuhiko Katunuma; Yoshio Hayashi
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

8.  Crystal structure of NS-134 in complex with bovine cathepsin B: a two-headed epoxysuccinyl inhibitor extends along the entire active-site cleft.

Authors:  Igor Stern; Norbert Schaschke; Luis Moroder; Dusan Turk
Journal:  Biochem J       Date:  2004-07-15       Impact factor: 3.857

9.  RNA interference in Schistosoma mansoni schistosomula: selectivity, sensitivity and operation for larger-scale screening.

Authors:  Saša Stefanić; Jan Dvořák; Martin Horn; Simon Braschi; Daniel Sojka; Debbie S Ruelas; Brian Suzuki; Kee-Chong Lim; Stephanie D Hopkins; James H McKerrow; Conor R Caffrey
Journal:  PLoS Negl Trop Dis       Date:  2010-10-19

10.  E64 [trans-epoxysuccinyl-L-leucylamido-(4-guanidino)butane] analogues as inhibitors of cysteine proteinases: investigation of S2 subsite interactions.

Authors:  B J Gour-Salin; P Lachance; M C Magny; C Plouffe; R Ménard; A C Storer
Journal:  Biochem J       Date:  1994-04-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.